Clinical trial
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
NCT06031389 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- December 31, 2025
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.